C3 and Alzheimer disease: This finding is consistent with early complement measurements in AD where it was reported that the levels of C1-INH did not increase to the same extent as the pathway components, such as C3 and complement proteins of the membrane attack complex, C5-C9 (Yasojima et al., 1999).